Health Winners & Losers: Vivus
Amylin is down 20.1%.
Health stocks were in a miserable state Wednesday and falling in line with the broader market, with the Nasdaq and Amex biotechnology indices shedding 3.5% and 4.8%, respectively.
Among individual stocks, notable movers were:
Vivus
(VVUS) - Get VIVUS, Inc. Report
, up 11.6% at $6.37
Pharmasset
(VRUS)
, up 7.1% at $17.41
Alpharma
(ALO) - Get Alio Gold Inc. Report
, up 6.2% at $30.64
Pain Therapeutics
(PTIE)
Scroll to Continue
TheStreet Recommends
, up 5.2% at $9.10
Amylin
( AMLN), down 20.1% at $6.66
Celera
( CRA), down 14% at $10.81
Human Genome Sciences
( HGSI), down 11.8% at $2
Illumina
(ILMN) - Get Illumina Inc. Report
, down 8.3% at $24.19
OSI Pharmaceuticals
( OSIP), down 5.6% at $37.08
This article was written by a staff member of TheStreet.com.
